BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-229@pharmaconomics
DTSTAMP:20260707T005947Z
DTSTART;VALUE=DATE:20260922
DTEND;VALUE=DATE:20260923
SUMMARY:IONS PDUFA — zilganersen
DESCRIPTION:The FDA's approval decision on zilganersen for Alexander disease is due Sep 22\, 2026. A green light opens the market\; a complete response letter (CRL) usually sinks the stock.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/874015/000114036126015801/ef20071051_8k.htm\n\nTrack it: https://www.pharmaconomics.com/e/229
URL:https://www.pharmaconomics.com/e/229
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:IONS catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR